Clinical Trial Update: Aquaresis Utility for Hyponatremic Acute Heart Failure Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for Aquaresis in hyponatremic acute heart failure has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Aquaresis (unknown)

Snippet

Sponsor: University of Southern California | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2019-05-28